Anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: Potential clinical value

Digestion

Volumn 66, Issue 3, 2002, Pages 173-177

  Glas, J ^b   Torok H P ^b   Vilsmaier, F ^b   Herbinger, K H ^b   Hoelscher, M ^b   Folwaczny, Christian ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

Anti Saccharomyces cerevisiae antibodies (ASCA); Crohn's disease; Immunoglobulin A (IgA); Immunoglobulin G (IgG); Infectious enterocolitis; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENTEROCOLITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FEMALE; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; PRIORITY JOURNAL; RELATIVE; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLAMMATORY BOWEL DISEASES; MALE; SACCHAROMYCES CEREVISIAE;

EID: 0036946773     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066760     Document Type: Article

References (28)

1. Cambridge G, Rampton DS, Stevens TR, McCarthy DA, Kamm M, Leaker B: Antineutrophil antibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1992;33:668-674.
2. Colombel JF, Reumaux D, Duthilleul P, Noel LH, Gower-Rousseau C, Paris JC, Cortot A: Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Gastroenterol Clin Biol 1992;16:656-660.
3. Das KM, Dubin R, Nagai T: Isolation and characterisation of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis. Proc Natl Acad Sci USA 1978;75:4528-4532.
4. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590-1596.
5. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F: Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991;100:1385-1391.
6. Fiocchi C, Roche JK, Michener WM: High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Intern Med 1989;110:786-794.
7. Folwaczny C, Noehl N, Endres SP, Heldwein W, Loeschke K, Fricke H: Antinuclear autoantibodies in patients with inflammatory bowel disease - High prevalence in first-degree relatives. Dig Dis Sci 1997;42:1593-1596.
8. Folwaczny C, Noehl N, Tschöpp K, Endres SP, Heldwein W, Loeschke K, Fricke H: Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology 1997;113:101-106.
9. Folwaczny C, Noehl N, Endres SP, Loeschke K, Fricke H: Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease. Scand J Gastroenterol 1998;33:523-528.
10. Folwaczny C, Loeschke K, Schnettler D, Jäger G, Wiebecke B, Hoelscher M, Sauer T, König A, Endres SP, Fricke H: Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection. Clin Immunol 2000;95:197-202.
11. Hibi T, Ohara M, Toda K, Hara A, Ogata H, Iwao Y, Watanabe N, Watanabe M, Hamada Y, Kobayashi K: In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis. Gut 1990;31:1371-1376.
12. Lee JC, Lennard-Jones JE, Cambridge G: Anti-neutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995;108:428-433.
13. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Pena AS, Dolman KM, Bril H, Dekker W, Nauta JJ: Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment. Gut 1993;34:46-50.
14. Seibold F, Weber P, Jenss H, Wiedmann KH: Antibodies to a trypsin-sensitive pancreatic antigen in chronic inflammatory bowel disease: Specific markers for a subgroup of patients with Crohn's disease. Gut 1991;32:1192-1197.
15. Stöcker W, Otte M, Ulrich S, Normann D, Finkbeiner H, Stocker K, Jantschek G, Scriba PC: Autoimmunity: Pancreatic juice in Crohn's disease. Scand J Gastroenterol 1987;22:41-52.
16. Yang H, Vora DK, Targan SR, Toyoda H, Beaudet AL, Rotter JI: Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology 1995;109:440-448.
17. Yang H, Rottler JI, Toyoda H, Landers C, Tyran D, McElree CK, Targan SR: Ulcerative colitis: A genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993;92:1080-1084.
18. Quinton JF, Sendid B, Reumaux B, Duthilleul P, Cartot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D: Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998;42:788-791.
19. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG: Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-829.
20. Sendid B, Colombel F, Jaquinot PM, Faille C, Fruit J, Cortot A, Lucidarme D, Camus D, Poulain D: Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996;3:219-226.
21. Annese V, Andreoli A, Andriulli A, D'Inca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF: Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study. Am J Gastroenterol 2001;96:2407-2412.
22. Seibold F, Stich O, Hufnagl R, Kamil S, Scheurlen M: Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: A family study. Scand J Gastroenterol 2001;36:196-201.
23. Sendid B, Quinton JF, Charrier G, Goulet O, Cartot A, Grandbastien B, Poulain D, Colombel JF: Anti-Saccharomyces cerevisiaemannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998;93:1306-1310.
24. Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P: Anti-Saccharomyces cerevisiaeantibodies, phenotypes of IBD, and intestinal permeability: A study in IBD families. Inflamm Bowel Dis 2001;7:8-15.
25. Vermeire S, Joosens S, Peeters M, Mansuur F, Marien G, Bossuyt X, Groenen P, Vlietinck R, Rutgeerts P: Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001;120:827-833.
26. Peeters M, Geypens B, Claus D, Nevens H, Ghoos Y, Verbeke G, Baert F, Vermeire S, Vlietinck R, Rutgeerts P: Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997;113:802-807.
27. Söderholm JD, Olaison G, Lindberg E, Hannestad U, Vindels A, Tysk C, Järnerot G, Sjödahl R: Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: An inherited defect in mucosal defence? Gut 1999;44:96-100.
28. Poulain D, Sendid B, Fajardi I, Danze PM, Colombel JF: Mother to child transmission of anti-Saccharomyces cerevisiae mannan antibodies in non-IBD families. Gut 2000;47:870-871.